Analystreport

Satsuma Pharmaceuticals, Inc. (NASDAQ: STSA) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating.

Satsuma Pharmaceuticals, Inc. - Common stock  (STSA) 
Last satsuma pharmaceuticals, inc. - common stock earnings: 3/10 04:01 pm Check Earnings Report